Position in EOLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$650,991
-$508,409 QoQ
Shares Held
158,392
-9.2% QoQ
Ownership
0.241%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
19 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in EOLS Over Time
Shares Held
Position Value (USD)
Derivatives in EOLS
reported options exposure · as of Mar 31, 2024CallValue
$350,000
CallShares
25,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Squarepoint Ops LLC holds $163,878,430 across 40 Drug Manufacturers - Specialty & Generic names. EOLS ranks #25 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
487,953 | $64,282,928 | |
| 2 | VTRS |
Viatris Inc
|
2,273,599 | $30,716,322 | |
| 3 | ALKS |
Alkermes plc.
|
277,619 | $9,816,607 | |
| 4 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
158,093 | $7,612,177 | |
| 5 | LQDA |
Liquidia Corp
|
161,689 | $6,102,142 | |
| 6 | TEVA |
Teva Pharmaceutical Industries Ltd
|
167,580 | $5,047,509 | |
| 7 | PRGO |
PERRIGO Co plc
|
464,742 | $4,991,329 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
63,538 | $4,886,072 |
All Filings in EOLS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $650,991 | 158,392 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,159,400 | 174,346 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $253,047 | 41,213 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $974,390 | 105,797 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $136,829 | 11,374 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $289,016 | 26,179 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,463,815 | 90,359 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $764,903 | 70,498 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $350,000 | 25,000 | Call | Defined | 2024-05-15 | |
| 2024-03-31 | $1,030,246 | 73,589 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,270,381 | 120,644 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $2,575,140 | 281,744 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,032,957 | 142,085 | Shares | Defined | 2023-08-14 | |
| 2022-09-30 | $701,935 | 87,197 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $361,328 | 31,149 | Shares | Defined | 2022-08-15 | |
| 2021-09-30 | $142,867 | 18,749 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $606,289 | 47,928 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $169,272 | 13,031 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $332,492 | 98,956 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $39,534 | 10,111 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||